Catalyst Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Catalyst Pharmaceuticals

09/08/2023 22:52

* Catalyst Pharmaceuticals Inc  CPRX.OQ  reported quarterly
adjusted earnings of 33 cents​​ per share for the quarter ended
in June. The mean expectation of five analysts for the quarter
was for earnings of 42 cents per share.
    * Revenue rose 87.5% to $99.58 million from a year ago;
analysts
expected $91.71 million. 
    * Catalyst Pharmaceuticals Inc's reported EPS for the
quarter was
33 cents​.
    * The mean earnings estimate of analysts had risen by
about 13.5%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates 
    * Catalyst Pharmaceuticals Inc shares had risen by 6.6% this
quarter and lost 23.0% so far this year.
    * The company reported quarterly net income of $37.76
million.
    * Wall Street's median 12-month price target for Catalyst
Pharmaceuticals Inc is $24.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:52 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.42           0.33           Missed
 Mar. 31 2023      0.32           0.26           Missed
 Dec. 31 2022      0.21           0.22           Beat
 Sep. 30 2022      0.19           0.20           Beat